Erratum: A novel antifungal is active against Candida albicans biofilms and inhibits mutagenic acetaldehyde production in vitro (PLoS ONE (2014) 9, 5 (e97864) DOI: 10.1371/journal.pone.0097864);A novel antifungal is active against Candida albicans biofilms and inhibits mutagenic acetaldehyde production in vitro

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Nieminen, Mikko T ^a,b,d   Novak Frazer, Lily ^d   Rautemaa, Vilma ^d   Rajendran, Ranjith ^e   Sorsa, Timo ^a,c   Ramage, Gordon ^e   Bowyer, Paul ^d   Rautemaa, Riina ^a,b,c,d  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e GLASGOW DENTAL HOSPITAL AND SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETALDEHYDE; ALKANOIC ACID; CASPOFUNGIN; DEXTRO 2 HYDROXYISOCAPROIC ACID; GLUCOSE; UNCLASSIFIED DRUG; ALPHA-HYDROXYISOCAPROIC ACID; ANTIFUNGAL AGENT; HEXANOIC ACID DERIVATIVE; MUTAGENIC AGENT;

ACIDITY; ARTICLE; BIOFILM; BIOMASS; CANDIDA ALBICANS; CELL GROWTH; CONTROLLED STUDY; DOWN REGULATION; FUNGAL CELL; FUNGUS HYPHAE; GAS CHROMATOGRAPHY; GENE EXPRESSION; GENETIC TRANSCRIPTION; IN VITRO STUDY; MUTAGENICITY; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCANNING ELECTRON MICROSCOPY; UPREGULATION; CANDIDIASIS; CELL PROLIFERATION; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION;

ACETALDEHYDE; ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA ALBICANS; CANDIDIASIS; CAPROATES; CELL PROLIFERATION; IN VITRO TECHNIQUES; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON, SCANNING; MUTAGENS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84901407960     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101859     Document Type: Erratum

References (86)

1. Brown GD, Denning DW, Gow NA, Levitz SM, Netea MG, et al. (2012) Hidden killers: human fungal infections. Sci Transl Med 4: 165rv113.
2. Costerton JW, Stewart PS, Greenberg EP (1999) Bacterial biofilms: a common cause of persistent infections. Science 284: 1318-1322. (Pubitemid 29289651)
3. Ramage G, Mowat E, Jones B, Williams C, Lopez-Ribot J (2009) Our current understanding of fungal biofilms. Crit Rev Microbiol 35: 340-355.
4. Taff HT, Mitchell KF, Edward JA, Andes DR (2013) Mechanisms of Candida biofilm drug resistance. Future Microbiol 8: 1325-1337.
5. Baillie GS, Douglas LJ (1999) Candida biofilms and their susceptibility to antifungal agents. Methods Enzymol 310: 644-656. (Pubitemid 29504312)
6. Ramage G, VandeWalle K, Lopez-Ribot JL, Wickes BL (2002) The filamentation pathway controlled by the Efg1 regulator protein is required for normal biofilm formation and development in Candida albicans. FEMS Microbiol Lett 214: 95-100. (Pubitemid 35245528)
7. Land GA, McDonald WC, Stjernholm RL, Friedman L (1975) Factors affecting filamentation in Candida albicans: changes in respiratory activity of Candida albicans during filamentation. Infect Immun 12: 119-127.
8. Setiadi ER, Doedt T, Cottier F, Noffz C, Ernst JF (2006) Transcriptional response of Candida albicans to hypoxia: linkage of oxygen sensing and Efg1p-regulatory networks. J Mol Biol 361: 399-411. (Pubitemid 44118339)
9. Vellucci VF, Gygax SE, Hostetter MK (2007) Involvement of Candida albicans pyruvate dehydrogenase complex protein X (Pdx1) in filamentation. Fungal Genet Biol 44: 979-990. (Pubitemid 47334888)
10. Vylkova S, Carman AJ, Danhof HA, Collette JR, Zhou H, et al. (2011) The fungal pathogen Candida albicans autoinduces hyphal morphogenesis by raising extracellular pH. MBio 2: e00055-00011.
11. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420: 860-867. (Pubitemid 36019639)
12. Marttila E, Uittamo J, Rusanen P, Lindqvist C, Salaspuro M, et al. (2013) Acetaldehyde production and microbial colonization in oral squamous cell carcinoma and oral lichenoid disease. Oral Surg Oral Med Oral Pathol Oral Radiol 116: 61-68.
13. Rautemaa R, Hietanen J, Niissalo S, Pirinen S, Perheentupa J (2007) Oral and oesophageal squamous cell carcinoma-a complication or component of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED, APS-I). Oral Oncol 43: 607-613. (Pubitemid 46856270)
14. Rautemaa R, Ramage G (2011) Oral candidosis-clinical challenges of a biofilm disease. Crit Rev Microbiol 37: 328-336.
15. Uittamo J, Siikala E, Kaihovaara P, Salaspuro M, Rautemaa R (2009) Chronic candidosis and oral cancer in APECED-patients: production of carcinogenic acetaldehyde from glucose and ethanol by Candida albicans . Int J Cancer 124: 754-756.
16. Secretan B, Straif K, Baan R, Grosse Y, El Ghissassi F, et al. (2009) A review of human carcinogens-Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol 10: 1033-1034.
17. Brooks PJ, Theruvathu JA (2005) DNA adducts from acetaldehyde: implications for alcohol-related carcinogenesis. Alcohol 35: 187-193. (Pubitemid 41079922)
18. Nieminen MT, Uittamo J, Salaspuro M, Rautemaa R (2009) Acetaldehyde production from ethanol and glucose by non-Candida albicans yeasts in vitro. Oral Oncol 45: e245-248.
19. Flores CL, Rodriguez C, Petit T, Gancedo C (2000) Carbohydrate and energy-yielding metabolism in non-conventional yeasts. FEMS Microbiol Rev 24: 507-529.
20. Inglis DO, Arnaud MB, Binkley J, Shah P, Skrzypek MS, et al. (2012) The Candida genome database incorporates multiple Candida species: multispecies search and analysis tools with curated gene and protein information for Candida albicans and Candida glabrata. Nucleic Acids Res 40: D667-674.
21. Bertram G, Swoboda RK, Gooday GW, Gow NA, Brown AJ (1996) Structure and regulation of the Candida albicans ADH1 gene encoding an immunogenic alcohol dehydrogenase. Yeast 12: 115-127. (Pubitemid 26059932)
22. Mukherjee PK, Mohamed S, Chandra J, Kuhn D, Liu S, et al. (2006) Alcohol dehydrogenase restricts the ability of the pathogen Candida albicans to form a biofilm on catheter surfaces through an ethanol-based mechanism. Infect Immun 74: 3804-3816. (Pubitemid 43993311)
23. Thomas DP, Viudes A, Monteagudo C, Lazzell AL, Saville SP, et al. (2006) A proteomic-based approach for the identification of Candida albicans protein components present in a subunit vaccine that protects against disseminated candidiasis. Proteomics 6: 6033-6041. (Pubitemid 44851388)
24. Maestre O, Garcia-Martinez T, Peinado RA, Mauricio JC (2008) Effects of ADH2 overexpression in Saccharomyces bayanus during alcoholic fermentation. Appl Environ Microbiol 74: 702-707. (Pubitemid 351225721)
25. Marttila E, Bowyer P, Sanglard D, Uittamo J, Kaihovaara P, et al. (2013) Fermentative 2-carbon metabolism produces carcinogenic levels of acetaldehyde in Candida albicans. Mol Oral Microbiol 28: 281-291.
26. Nobile CJ, Nett JE, Hernday AD, Homann OR, Deneault JS, et al. (2009) Biofilm matrix regulation by Candida albicans Zap1. PLoS Biol 7: e1000133.
27. Cherry JM, Hong EL, Amundsen C, Balakrishnan R, Binkley G, et al. (2012) Saccharomyces Genome Database: the genomics resource of budding yeast. Nucleic Acids Res 40: D700-705.
28. Strijbis K, van Roermund CW, Hardy GP, van den Burg J, Bloem K, et al. (2009) Identification and characterization of a complete carnitine biosynthesis pathway in Candida albicans. FASEB J 23: 2349-2359.
29. Strijbis K, van Roermund CW, Visser WF, Mol EC, van den Burg J, et al. (2008) Carnitine-dependent transport of acetyl coenzyme A in Candida albicans is essential for growth on nonfermentable carbon sources and contributes to biofilm formation. Eukaryot Cell 7: 610-618. (Pubitemid 351959895)
30. Martinez-Gomariz M, Perumal P, Mekala S, Nombela C, Chaffin WL, et al. (2009) Proteomic analysis of cytoplasmic and surface proteins from yeast cells, hyphae, and biofilms of Candida albicans. Proteomics 9: 2230-2252.
31. Seneviratne CJ, Wang Y, Jin L, Abiko Y, Samaranayake LP (2008) Candida albicans biofilm formation is associated with increased anti-oxidative capacities. Proteomics 8: 2936-2947.
32. Stichternoth C, Ernst JF (2009) Hypoxic adaptation by Efg1 regulates biofilm formation by Candida albicans. Appl Environ Microbiol 75: 3663-3672.
33. Carman AJ, Vylkova S, Lorenz MC (2008) Role of acetyl coenzyme A synthesis and breakdown in alternative carbon source utilization in Candida albicans. Eukaryot Cell 7: 1733-1741.
34. Hernaez ML, Ximenez-Embun P, Martinez-Gomariz M, Gutierrez-Blazquez MD, Nombela C, et al. (2010) Identification of Candida albicans exposed surface proteins in vivo by a rapid proteomic approach. J Proteomics 73: 1404-1409.
35. Monteoliva L, Martinez-Lopez R, Pitarch A, Hernaez ML, Serna A, et al. (2011) Quantitative proteome and acidic subproteome profiling of Candida albicans yeast-to-hypha transition. J Proteome Res 10: 502-517.
36. Pierce JV, Dignard D, Whiteway M, Kumamoto CA (2013) Normal adaptation of Candida albicans to the murine gastrointestinal tract requires Efg1p-dependent regulation of metabolic and host defense genes. Eukaryot Cell 12: 37-49.
37. Cornely OA, Bassetti M, Calandra T, Garbino J, Kullberg BJ, et al. (2012) ESCMID*guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect 18 Suppl 7: 19-37.
38. Deresinski SC, Stevens DA (2003) Caspofungin. Clin Infect Dis 36: 1445-1457. (Pubitemid 36702880)
39. Pfaller M, Boyken L, Hollis R, Kroeger J, Messer S, et al. (2011) Use of epidemiological cutoff values to examine 9-year trends in susceptibility of Candida species to anidulafungin, caspofungin, and micafungin. J Clin Microbiol 49: 624-629.
40. Pfaller MA, Boyken L, Hollis RJ, Messer SA, Tendolkar S, et al. (2006) In vitro susceptibilities of Candida spp. to caspofungin: four years of global surveillance. J Clin Microbiol 44: 760-763.
41. Stevens DA, Espiritu M, Parmar R (2004) Paradoxical effect of caspofungin: reduced activity against Candida albicans at high drug concentrations. Antimicrob Agents Chemother 48: 3407-3411. (Pubitemid 39129338)
42. Walker LA, Gow NA, Munro CA (2013) Elevated chitin content reduces the susceptibility of Candida species to caspofungin. Antimicrob Agents Chemother 57: 146-154.
43. Sakko M, Moore C, Novak-Frazer L, Rautemaa V, Sorsa T, et al. (2013) 2-hydroxyisocaproic acid is fungicidal for Candida and Aspergillus species. Mycoses 57:214-221.
44. Sakko M, Tjaderhane L, Sorsa T, Hietala P, Jarvinen A, et al. (2012) 2-Hydroxyisocaproic acid (HICA): a new potential topical antibacterial agent. Int J Antimicrob Agents 39: 539-540.
45. Guo J, Brosnan B, Furey A, Arendt E, Murphy P, et al. (2012) Antifungal activity of Lactobacillus against Microsporum canis, Microsporum gypseum and Epidermophyton floccosum. Bioeng Bugs 3: 104-113.
46. Hietala PK, Westermarck HW, Jaarma M (1979) Identification of antimicrobial alpha-hydroxyacids in Lactobacillus plantarum-fermented animal protein. Nutr Metab 23: 227-234. (Pubitemid 9126872)
47. Mero AA, Ojala T, Hulmi JJ, Puurtinen R, Karila TA, et al. (2010) Effects of alfa-hydroxy-isocaproic acid on body composition, DOMS and performance in athletes. J Int Soc Sports Nutr 7: 1.
48. Boebel KP, Baker DH (1982) Comparative utilization of the alpha-keto and Dand L-alpha-hydroxy analogs of leucine, isoleucine and valine by chicks and rats. J Nutr 112: 1929-1939. (Pubitemid 13212901)
49. Westermarck HW, Hietala P, Jaarma M, Sorsa T, Vaara M (1997) Use of alpha-hydroxy acids in the manufacture of a medicament for the treatment of inflammation. European Patent Office. Patent no.EP0871438B1.
50. Crowley S, Mahony J, van Sinderen D (2012) Comparative analysis of two antifungal Lactobacillus plantarum isolates and their application as bioprotectants in refrigerated foods. J Appl Microbiol 113: 1417-1427.
51. Crowley S, Mahony J, van Sinderen D (2013) Broad-spectrum antifungal-producing lactic acid bacteria and their application in fruit models. Folia Microbiol (Praha) 58: 291-299.
52. Kohler GA, Assefa S, Reid G (2012) Probiotic interference of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 with the opportunistic fungal pathogen Candida albicans. Infect Dis Obstet Gynecol 2012: 636474.
53. Bachmann SP, VandeWalle K, Ramage G, Patterson TF, Wickes BL, et al. (2002) In vitro activity of caspofungin against Candida albicans biofilms. Antimicrob Agents Chemother 46: 3591-3596. (Pubitemid 35192931)
54. Ramage G, Milligan S, Lappin DF, Sherry L, Sweeney P, et al. (2012) Antifungal, cytotoxic, and immunomodulatory properties of tea tree oil and its derivative components: potential role in management of oral candidosis in cancer patients. Front Microbiol 3: 220.
55. Ahn SJ, Costa J, Emanuel JR (1996) PicoGreen quantitation of DNA: effective evaluation of samples pre- or post-PCR. Nucleic Acids Res 24: 2623-2625. (Pubitemid 26237167)
56. Marstorp H, Witter E (1999) Extractable dsDNA and product formation as measures of microbial growth in soil upon substrate addition. Soil Biol Biochem 31: 1443-1453. (Pubitemid 29347781)
57. Ramage G, Lopez-Ribot JL (2005) Techniques for antifungal susceptibility testing of Candida albicans biofilms. Methods Mol Med 118: 71-79.
58. Saravanan P, Pakshirajan K, Saha P (2009) Batch growth kinetics of an indigenous mixed microbial culture utilizing m-cresol as the sole carbon source. J Hazard Mater 162: 476-481.
59. Gillum AM, Tsay EY, Kirsch DR (1984) Isolation of the Candida albicans gene for orotidine-5′-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol Gen Genet 198: 179-182. (Pubitemid 15180998)
60. Wilson K (1987) Large scale CsCl preparation of genomic DNA from bacteria. In: Ausubel FMR, Brent, R.E.,Kingston, D.D., Moore, J.G., Seidman, J.A., Smith, K. . Struhl, editor. Current Protocols in Molecular Biology. New York: Greene Publishing Associates and Wiley Interscience. 2.4.3-2.4.5.
61. Untergasser A, Nijveen H, Rao X, Bisseling T, Geurts R, et al. (2007) Primer3Plus, an enhanced web interface to Primer3. Nucleic Acids Res 35: W71-74.
62. Nailis H, Coenye T, Van Nieuwerburgh F, Deforce D, Nelis HJ (2006) Development and evaluation of different normalization strategies for gene expression studies in Candida albicans biofilms by real-time PCR. BMC Mol Biol 7: 25.
63. Pfaffl MW, Horgan GW, Dempfle L (2002) Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30: e36.
64. Erlandsen SL, Kristich CJ, Dunny GM, Wells CL (2004) High-resolution visualization of the microbial glycocalyx with low-voltage scanning electron microscopy: dependence on cationic dyes. J Histochem Cytochem 52: 1427-1435. (Pubitemid 39518678)
65. Ingham CJ, Schneeberger PM (2012) Microcolony imaging of Aspergillus fumigatus treated with echinocandins reveals both fungistatic and fungicidal activities. PLoS One 7: e35478.
66. Hennicke F, Grumbt M, Lermann U, Ueberschaar N, Palige K, et al. (2013) Factors supporting cysteine tolerance and sulfite production in Candida albicans. Eukaryot Cell 12: 604-613.
67. Park S, Imlay JA (2003) High levels of intracellular cysteine promote oxidative DNA damage by driving the fenton reaction. J Bacteriol 185: 1942-1950. (Pubitemid 36297894)
68. Wain WH, Price MF, Cawson RA (1975) A re-evaluation of the effect of cysteine or Candida albicans. Sabouraudia 13 Pt 1: 74-82.
69. Winsten S, Murray TJ (1956) Virulence enhancement of a filamentous strain of Candida albicans after growth on media containing cysteine. J Bacteriol 71: 738.
70. Walraven CJ, Lee SA (2013) Antifungal lock therapy. Antimicrob Agents Chemother 57: 1-8.
71. Peng GS, Yin SJ (2009) Effect of the allelic variants of aldehyde dehydrogenase ALDH2*2 and alcohol dehydrogenase ADH1B*2 on blood acetaldehyde concentrations. Hum Genomics 3: 121-127.
72. Saint-Prix F, Bonquist L, Dequin S (2004) Functional analysis of the ALD gene family of Saccharomyces cerevisiae during anaerobic growth on glucose: the NADP+- dependent Ald6p and Ald5p isoforms play a major role in acetate formation. Microbiology 150: 2209-2220. (Pubitemid 39127363)
73. Vediyappan G, Rossignol T, d'Enfert C (2010) Interaction of Candida albicans biofilms with antifungals: transcriptional response and binding of antifungals to beta-glucans. Antimicrob Agents Chemother 54: 2096-2111.
74. Shirtliff ME, Krom BP, Meijering RA, Peters BM, Zhu J, et al. (2009) Farnesol-induced apoptosis in Candida albicans. Antimicrob Agents Chemother 53: 2392-2401.
75. Homann N, Jousimies-Somer H, Jokelainen K, Heine R, Salaspuro M (1997) High acetaldehyde levels in saliva after ethanol consumption: methodological aspects and pathogenetic implications. Carcinogenesis 18: 1739-1743. (Pubitemid 28134679)
76. Salaspuro M (2009) Acetaldehyde as a common denominator and cumulative carcinogen in digestive tract cancers. Scand J Gastroenterol 44: 912-925.
77. Uittamo J, Nieminen MT, Kaihovaara P, Bowyer P, Salaspuro M, et al. (2010) Xylitol inhibits carcinogenic acetaldehyde production by Candida species. Int J Cancer 129: 2038-2041.
78. Kim J, Sudbery P (2011) Candida albicans, a major human fungal pathogen. J Microbiol 49: 171-177.
79. Dowd SE, Delton Hanson J, Rees E, Wolcott RD, Zischau AM, et al. (2011) Survey of fungi and yeast in polymicrobial infections in chronic wounds. J Wound Care 20: 40-47.
80. Mousa HA, Al-Bader SM, Hassan DA (1999) Correlation between fungi isolated from burn wounds and burn care units. Burns 25: 145-147. (Pubitemid 29134670)
81. Odds FC (1979) Candida and candidosis Baltimore: University Park Press. 382 p.
82. Samaranayake LP, Keung Leung W, Jin L (2009) Oral mucosal fungal infections. Periodontol 2000 49: 39-59.
83. Sobel JD (2007) Vulvovaginal candidosis. Lancet 369: 1961-1971.
84. Kucharikova S, Tournu H, Lagrou K, Van Dijck P, Bujdakova H (2011) Detailed comparison of Candida albicans and Candida glabrata biofilms under different conditions and their susceptibility to caspofungin and anidulafungin. J Med Microbiol 60: 1261-1269.
85. Tirosh A, Shai I, Tekes-Manova D, Israeli E, Pereg D, et al. (2005) Normal fasting plasma glucose levels and type 2 diabetes in young men. N Engl J Med 353: 1454-1462. (Pubitemid 41400919)
86. Tumbarello M, Fiori B, Trecarichi EM, Posteraro P, Losito AR, et al. (2012) Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital. PLoS One 7: e33705.